What Is Acute Rejection? Causes, Symptoms, and Early Detection
Acute rejection is one of the most serious complications following an organ transplant. It occurs when the recipient's immune system recognizes the transplanted organ as foreign tissue and mounts an attack to destroy it. Understanding what triggers acute rejection, how to recognize its signs, and how quickly it must be treated can mean the difference between a functioning graft and organ loss.
The Immunological Basis of Acute Rejection
The immune system is designed to eliminate foreign threats. After transplantation, T-lymphocytes in the recipient's blood recognize donor-derived human leukocyte antigens (HLA) on the surface of transplanted cells as non-self. This triggers a cascade of immune activation: T-cells proliferate, cytotoxic CD8+ cells are recruited to attack graft tissue, and B-cells may produce donor-specific antibodies that engage complement pathways. The Banff classification system, developed by transplant pathologists worldwide, grades acute rejection severity from borderline through severe based on biopsy findings of tubulitis, intimal arteritis, and glomerulitis. Understanding these mechanisms explains why immunosuppressive regimens must be precisely maintained — any gap in coverage opens a window for immune activation.
Recognizing Symptoms in Kidney, Liver, and Heart Transplants
Symptoms of acute rejection vary by organ type and may be subtle in patients on modern triple-drug immunosuppression. Kidney transplant recipients may notice decreased urine output, swelling over the graft site, fatigue, and a rise in serum creatinine. Liver recipients may present with elevated liver enzymes (ALT, AST, bilirubin), right upper quadrant discomfort, and jaundice. Heart transplant patients often lack classic symptoms in the early stages — rejection may only be detected through routine endomyocardial biopsy, which is the gold standard for cardiac rejection surveillance. Fever was historically a warning sign but is now less reliable because modern immunosuppression frequently masks the inflammatory response. Any unexplained change in organ function should prompt immediate evaluation.
Diagnostic Tools and Biopsy
Laboratory panels are the first line of investigation when rejection is suspected. Kidney rejection workup includes serum creatinine, BUN, urinalysis, and measurement of tacrolimus or cyclosporine trough levels to rule out subtherapeutic immunosuppression. Donor-specific antibody (DSA) testing via single-antigen bead assay can identify antibody-mediated rejection (AMR) before biopsy. Ultrasound with Doppler is used to assess blood flow and rule out mechanical obstructions. Tissue biopsy remains the definitive diagnostic tool: core needle biopsies are interpreted according to Banff criteria, with histological findings guiding treatment intensity. Emerging biomarkers — including urinary CXCL9 and CXCL10 in kidney transplants — show promise as non-invasive surrogates for biopsy in routine monitoring.
The Importance of Early Detection and Treatment Windows
Time is critical in managing acute rejection. Episodes detected and treated within the first 24–48 hours carry significantly better graft survival rates than those identified after significant histological damage has occurred. High-dose corticosteroid pulse therapy (typically IV methylprednisolone 500–1000 mg daily for three days) is the standard first-line treatment for T-cell-mediated rejection and reverses the majority of episodes when administered promptly. Antibody-mediated rejection requires more intensive intervention: plasmapheresis, intravenous immunoglobulin (IVIG), rituximab, and/or bortezomib may be used depending on protocol. Patient and caregiver education — including when to contact the transplant center and why adherence to monitoring appointments matters — is the most powerful tool for ensuring timely diagnosis.
Conclusion
Acute rejection is a complex immunological event that demands prompt recognition and treatment. Patients, families, and caregivers who understand the warning signs and maintain consistent follow-up with their transplant team are best positioned to protect graft function. For more educational resources on transplant health, visit our homepage or contact our medical education team.